Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound Guided ESPB in Scoliotic Adolescents
NCT03968146Phase 2Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jun 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in scoliosis (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Total morphine consumption at 24 hours. Started Jun 2019; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
scoliosis
Beyond the preview
Go deeper on NCT03968146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03968146.